AAAAAA
Results:
1-23
|
Results: 23
Authors:
Tarnow, L
Grarup, N
Hansen, T
Parving, HH
Pedersen, O
Citation: L. Tarnow et al., Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients, NEPH DIAL T, 16(8), 2001, pp. 1653-1656
Authors:
Hovind, P
Tarnow, L
Rossing, P
Teerlink, T
Stehouwer, CDA
Emeis, JJ
Parving, HH
Citation: P. Hovind et al., Progression of diabetic nephropathy: Role of plasma homocysteine and plasminogen activator inhibitor-1, AM J KIDNEY, 38(6), 2001, pp. 1376-1380
Authors:
Hovind, P
Rossing, P
Tarnow, L
Toft, H
Parving, J
Parving, HH
Citation: P. Hovind et al., Remission of nephrotic-range albuminuria in type 1 diabetic patients, DIABET CARE, 24(11), 2001, pp. 1972-1977
Authors:
Hovind, P
Rossing, P
Tarnow, L
Smidt, UM
Parving, HH
Citation: P. Hovind et al., Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively, KIDNEY INT, 60(1), 2001, pp. 277-283
Authors:
Hovind, P
Rossing, P
Tarnow, L
Smidt, UM
Parving, HH
Citation: P. Hovind et al., Progression of diabetic nephropathy, KIDNEY INT, 59(2), 2001, pp. 702-709
Authors:
Hansen, HP
Lund, SS
Rossing, P
Tarnow, L
Nielsen, FS
Jensen, T
Parving, HH
Citation: Hp. Hansen et al., Preventing diabetic nephropathy: an audit, SC J CL INV, 61(6), 2001, pp. 471-477
Authors:
Poirier, O
Nicaud, V
Vionnet, N
Raoux, S
Tarnow, L
Vlassara, H
Parving, HH
Cambien, F
Citation: O. Poirier et al., Polymorphism screening of four genes encoding advanced glycation end-product putative receptors - Association study with nephropathy in type 1 diabetic patients, DIABETES, 50(5), 2001, pp. 1214-1218
Authors:
van Ittersum, FJ
de Man, AME
Thijssen, S
de Knijff, P
Slagboom, E
Smulders, Y
Tarnow, L
Donker, AJM
Bilo, HJG
Stehouwer, CDA
Citation: Fj. Van Ittersum et al., Genetic polymorphisms of the renin-angiotensin system and complications ofinsulin-dependent diabetes mellitus, NEPH DIAL T, 15(7), 2000, pp. 1000-1007
Authors:
Tarnow, L
Stehouwer, CDA
Emeis, JJ
Poirier, O
Cambien, F
Hansen, BV
Parving, HH
Citation: L. Tarnow et al., Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy, NEPH DIAL T, 15(5), 2000, pp. 625-630
Authors:
Johannesen, J
Tarnow, L
Parving, HH
Nerup, J
Pociot, F
Citation: J. Johannesen et al., CCTTT-repeat polymorphism in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients, DIABET CARE, 23(4), 2000, pp. 560-562
Authors:
Tarnow, L
Rossing, P
Jensen, C
Hansen, BV
Parving, HH
Citation: L. Tarnow et al., Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy, DIABET CARE, 23(12), 2000, pp. 1725-1730
Authors:
Tarnow, L
Fagerudd, JA
Rossing, P
Poirier, O
Nielsen, FS
Parving, HH
Citation: L. Tarnow et al., Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy, DIABET CARE, 23(1), 2000, pp. 30-33
Authors:
Hovind, P
Tarnow, L
Oestergaard, PB
Parving, HH
Citation: P. Hovind et al., Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy, KIDNEY INT, 57, 2000, pp. S56-S61
Authors:
Andersen, S
Tarnow, L
Rossing, P
Hansen, BV
Parving, HH
Citation: S. Andersen et al., Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy, KIDNEY INT, 57(2), 2000, pp. 601-606
Authors:
Tarnow, L
Kjeld, T
Knudsen, E
Major-Pedersen, A
Parving, HH
Citation: L. Tarnow et al., Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in Type I diabetic patients, DIABETOLOG, 43(6), 2000, pp. 794-799
Authors:
Deinum, J
Tarnow, L
van Gool, JM
de Bruin, RA
Derkx, FHM
Schalekamp, MADH
Parving, HH
Citation: J. Deinum et al., Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy, NEPH DIAL T, 14(8), 1999, pp. 1904-1911
Authors:
Tarnow, L
Urhammer, SA
Mottlau, B
Hansen, BV
Pedersen, O
Parving, HH
Citation: L. Tarnow et al., The Trp64Arg amino acid polymorphism of the beta(3)-adrenergic receptor gene does not contribute to the genetic susceptibility of diabetic microvascular complications in Caucasian type 1 diabetic patients, NEPH DIAL T, 14(4), 1999, pp. 895-897
Authors:
Parving, HH
Tarnow, L
Nielsen, FS
Rossing, P
Mandrup-Poulsen, T
Osterby, R
Nerup, J
Citation: Hh. Parving et al., Cyclosporine nephrotoxicity in type 1 diabetic patients A 7-year follow-up study, DIABET CARE, 22(3), 1999, pp. 478-483
Authors:
Tarnow, L
Sato, A
Ali, S
Rossing, P
Nielsen, FS
Parving, HH
Citation: L. Tarnow et al., Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy, DIABET CARE, 22(3), 1999, pp. 491-494
Authors:
Jacobsen, P
Rossing, K
Tarnow, L
Rossing, P
Mallet, C
Poirier, O
Cambien, F
Parving, HH
Citation: P. Jacobsen et al., Progression of diabetic nephropathy in normotensive type 1 diabetic patients, KIDNEY INT, 56, 1999, pp. S101-S105
Authors:
Sato, A
Tarnow, L
Parving, HH
Citation: A. Sato et al., Prevalence of left ventricular hypertrophy in Type I diabetic patients with diabetic nephropathy, DIABETOLOG, 42(1), 1999, pp. 76-80
Authors:
Schalkwijk, CG
Ligtvoet, N
Twaalfhoven, H
Jager, A
Blaauwgeers, HGT
Schlingemann, RO
Tarnow, L
Parving, HH
Stehouwer, CDA
van Hinsbergh, VWM
Citation: Cg. Schalkwijk et al., Amadori albumin in type 1 diabetic patients - Correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries, DIABETES, 48(12), 1999, pp. 2446-2453
Authors:
Sorensen, VB
Rossing, P
Tarnow, L
Parving, HH
Norgaard, T
Kastrup, J
Citation: Vb. Sorensen et al., Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy, CLIN SCI, 95(6), 1998, pp. 709-717
Risultati:
1-23
|